Real World Evidence (RWE) to Enhance Value-Based Market Access of the PCSK9 Inihibitors in Italy- Treatment Patterns and Cv-Related Hospitalizations Among High Risk Hefh and Secondary Prevention Patients in Three Real-World Data Systems

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1821
https://www.valueinhealthjournal.com/article/S1098-3015(16)33187-4/fulltext
Title : Real World Evidence (RWE) to Enhance Value-Based Market Access of the PCSK9 Inihibitors in Italy- Treatment Patterns and Cv-Related Hospitalizations Among High Risk Hefh and Secondary Prevention Patients in Three Real-World Data Systems
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33187-4&doi=10.1016/j.jval.2016.09.1821
First page : A663
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1720
Categories :
Tags :
Regions :
ViH Article Tags :